- Home
- AEYE vs XBIT Comparison
AEYE vs XBIT Comparison
Compare AEYE & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEYE
- XBIT
- Stock Information
- Founded
- AEYE 2005
- XBIT 2005
- Country
- AEYE United States
- XBIT United States
- Employees
- AEYE N/A
- XBIT N/A
- Industry
- AEYE Computer Software: Prepackaged Software
- XBIT Pharmaceuticals and Biotechnology
- Sector
- AEYE Technology
- XBIT Health Care
- Exchange
- AEYE Nasdaq
- XBIT Nasdaq
- Market Cap
- AEYE 205.3M
- XBIT 194.5M
- IPO Year
- AEYE N/A
- XBIT 2015
- Fundamental
- Price
- AEYE $17.22
- XBIT $3.82
- Analyst Decision
- AEYE Strong Buy
- XBIT
- Analyst Count
- AEYE 5
- XBIT 0
- Target Price
- AEYE $29.10
- XBIT N/A
- AVG Volume (30 Days)
- AEYE 253.3K
- XBIT 94.1K
- Earning Date
- AEYE 03-05-2025
- XBIT 11-13-2024
- Dividend Yield
- AEYE N/A
- XBIT N/A
- EPS Growth
- AEYE N/A
- XBIT N/A
- EPS
- AEYE N/A
- XBIT N/A
- Revenue
- AEYE $33,348,000.00
- XBIT N/A
- Revenue This Year
- AEYE $14.66
- XBIT N/A
- Revenue Next Year
- AEYE $21.01
- XBIT N/A
- P/E Ratio
- AEYE N/A
- XBIT N/A
- Revenue Growth
- AEYE 6.94
- XBIT N/A
- 52 Week Low
- AEYE $4.52
- XBIT $3.51
- 52 Week High
- AEYE $34.85
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- AEYE 49.44
- XBIT 32.16
- Support Level
- AEYE $13.61
- XBIT $3.64
- Resistance Level
- AEYE $16.48
- XBIT $4.00
- Average True Range (ATR)
- AEYE 1.12
- XBIT 0.34
- MACD
- AEYE 0.46
- XBIT 0.02
- Stochastic Oscillator
- AEYE 94.26
- XBIT 17.48
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.